Congress Materials – Myasthenia Gravis Foundation of America (MGFA 2024)
2024 Myasthenia Gravis Foundation of America | Oct 15 | Savannah, GA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
A Randomized, Open-Label Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
Marta Cossu, Carolina Bobadilla Mendez, Amanda Jackson, Eugene Myshkin, Grace Liu, Edwin Lam, Ulf H Beier, Kathleen Weisel, Brittney Scott, Jocelyn H Leu, Sheng Gao, Dessislava Dimitrova
Adverse pregnancy outcomes in myasthenia gravis: A retrospective cohort study in a US health insurance claims database
Melanie H. Jacobson, Rupa Makadia, John Sheehan, Nathan Hall, Jill Hardin, Sicong Huang, Ran Sun, Rebecca Zaha, Alexis A. Krumme
Assessing the suitability of the Neuro-QoL Fatigue to evaluate fatigue in patients living with Myasthenia Gravis
Sheryl Pease, Kayla Scippa
Disease burden in patients with generalized Myasthenia Gravis
Nicholas Silvestri, Maria Ait-Tihyaty, Kavita Gandhi, Ibrahim Turkoz, Mehmet Daskiran, Bonnie C. Shaddinger, Ewa Lindenstrom
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 Vivacity-MG3 Study
Tuan Vu, Carlo Antozzi, Sindhu Ramchandren, Richard J. Nowak, Constantine Farmakidis, Vera Bril, Jan De Bleecker, Huan Yang, Eduard Minks, Jin-Sung Park, Mariusz Grudniak, Marek Smilowski, Teresa Sevilla, Sarah Hoffmann, Kumaraswamy Sivakumar, Eriene Youssef, Panna Sanga, Keith Karcher, Yaowei Zhu, Leona E. Ling, Hong Sun
Factors influencing exacerbations and crisis in generalized myasthenia gravis: Findings from a claims database study
Louis Jackson, Zhiwen Liu, Jacqueline Pesa, Alicia K Campbell, Zia Choudhry, Alberto E Batista, Qian Cai, Nizar Souayah
Impact of Race and Social Determinants of Health on Exacerbations in Generalized Myasthenia Gravis
Louis Jackson, Zhiwen Liu, Jacqueline Pesa, Alicia K Campbell, Ashley Anderson
Leveraging AI to characterize mental health experiences throughout the Myasthenia Gravis diagnosis journey
Raghav Govindarajan, Rachelle D. Rodriguez, Zia Choudhry, Caroline Brethenoux, Jacqui Pesa, Sindhu Ramchandren, Nolan Campbell, Kavita Gandhi, Kristin Heerlein, Nizar Souayah, Ashley E.L. Anderson
Partnering with Patients and Caregivers to Guide the Development of Impactful Study Engagement Tools in a Generalized Myasthenia Gravis Real World Study
Jessica Wright, Marcia Landen, Maria Ait-Tihyaty, Brindley Rospars, Brian Sawyer, Zia Choudhry, Lisa Shea
Perinatal treatment patterns in myasthenia gravis
Melanie H. Jacobson, Rupa Makadia, Anna Ostropolets, John Sheehan, Sicong Huang, Rebecca Zaha, Alexis A. Krumme
Post-hoc Analysis Of Clinically Relevant Anti-vaccine Antibodies In Participants Treated With Nipocalimab
Faye Yu, Eugene Myshkin, Carolina Bobadilla Mendez, Marta Cossu, Kaiyin Fei, Qingmin Wang, Matthew J. Loza, Dessislava Dimitrova, Sheng Gao
Post-hoc evaluation of the clinical effects of nipocalimab, a new neonatal fragment crystallizable blocker, over time in the Vivacity-MG3 study
Richard Nowak, Maria Ait-Tihyaty, Ibrahim Turkoz, Kavita Gandhi, Rachelle Rodriguez, Sarah Gingerich, Sheryl Pease, Hans Katzberg
Safety and effectiveness of nipocalimab in adolescent participants in the open label Phase 2/3 VIBRANCE-MG clinical study
Jonathan Strober, Shawn Black, Sindhu Ramchandren, Saunder Bernes, Akiyuki Uzawa, Yasuhiro Kimoto, Keiko Ishigaki, Tuan Vu, Dan Huang, Yaowei Zhu, Hong Sun
Sentiment Analysis of Digital Conversations Related to Myasthenia Gravis by Race/Ethnicity
Nizar Souayah, Caroline Brethenoux, Alyssa DeLuca, Jacqueline Pesa, Louis Jackson, Zia Choudhry, Patrick Furey, Rosario Alvarez, Laura González Quijano, Alex Lorenzo, Ashley Anderson
Symptom Severity Assessment Using MG-ADL Items and Domains in a 24-week, Phase 3 Study (Vivacity) of Nipocalimab in Generalized Myasthenia Gravis
Constantine Farmakidis, Kavita Gandhi, Maria Ait-Tihyaty, Ibrahim Turkoz, Sheryl Pease, Zia Choudhry, Charlotte Gary, Antoine C El Khoury, Sindhu Ramchandren
Uncontrolled myasthenia gravis can contribute to additional stress burden and adverse mental health experiences
Kelly Gwathmey, Rachelle Rodriguez, Zia Choudhry, Louis Jackson, Wesley Peters, Gabrielle Geonnotti, Sindhu Ramchandren, Maria Ait-Tihyaty, Neelam Goyal
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.